+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Heparin Market in Europe is Expected to Reach USD 3.14 Billion by 2022

Posted on Jun 11, 2015

According to a new market report published by Transparency Market Research Heparin Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2022” the Europe heparin market was valued at USD 2,004.5 million in 2013 and is estimated to reach USD 3,148.0 million by 2022 growing with a CAGR of 5.2% from 2014 to 2022.

 

Browse the full Heparin Market (Unfractionated Heparin, Low Molecular Weight Heparin & Ultra Low Molecular Weight Heparin) - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 report at https://www.transparencymarketresearch.com/europe-heparin-market.html

 

Heparin is an anticoagulant majorly sourced from porcine intestine or bovine lungs and is commonly employed during surgical procedures wherein chances of clot formation is high. Heparin is preferably administered through intravenous or subcutaneous route due to its low absorption in human intestine Heparin is the second most leading anticoagulant used worldwide after warfarin. 

 

The Europe heparin market is segmented by product and country. Based on the product types, the market is categorized into unfractionated heparin, low molecular weight heparin (LMWHs) and ultra-low molecular weight heparin (ULMWHs). Whereas the market by country has been analyzed for five major European countries; Germany, France, United Kingdom, Italy, Spain and Rest of the Europe. Low molecular weight heparin is the majorly used product in Europe with a share of more than 80% in 2013. This is owing to the fact that compared to the traditional unfractionated heparin, low molecular weight heparin is safe and cost effective solution for the treatment of blood clots. Enoxaparin, dalteparin, and tinzaparin are the major brands of low molecular weight heparin sold in the European market. Ultra-low molecular weight heparin being new to the market is gaining market share gradually with increasing studies justifying its better pharmacodynamics effect in treating clots in cardiovascular and neurological conditions. This market will be growing at a CAGR of 3.0% during the forecast period 2014 – 2022.

 

Geographically the market is majorly driven by developed European countries such as France, Germany and United Kingdom. Germany accounted for largest market share of approximately 12.0% in 2013 among the EU5 countries and is expected to grow rapidly with a CAGR of 6.0%. Key growth attributes for Germany heparin market include high consumption, large geriatric population base and increasing number of surgical procures such as knee replacement, hip surgeries, and cardiovascular surgeries among others. Additionally, high incidence and prevalence of VTE in Germany is another factor augmenting the growth and consumption of heparin based formulation in last few years. According to the VITAE study, around 460,000 people in France develop DVT, including 300,000 cases of PE. Owing to this factor coupled with the rapidly aging population in France, the heparin market is highly attractive in France after Germany and will be growing at a CAGR of more than 5.0% during the forecast period. Uncertain economic conditions in rest of the European countries is negatively impacting the demand for heparin in this region. Moreover, as the regulations pertaining to the extraction and processing of crude heparin has become stringent post contaminations issues of heparin imported form the Chinese suppliers, Europe is expected to be the major heparin supplier to the world. Manufactures are now focusing on establishing manufacturing and processing plants in Europe to curtail the cost and enhance the product quality. An increase in the cost of raw heparin will impact the prices of end product. 

 

Nearly one third of the citizens of Europe would be aged 65 years and above by 2060. As aging is a major contributing factor for coagulation disorders demand for heparin will augment during the forecast period. Biosimilar heparin products would be a great opportunity for both new and existing players. Moreover, establishment of regulatory framework for biosimilars in the European Union for the marketing authorization is likely to augment the demand for biosimilar-based heparin products in the next few years. 

 

Some of the key players profiled in this report include Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Leo Pharma A/S, Pfizer, Inc., Sanofi S.A., and Syntex S.A. Sanofi S.A. was the dominant player in with approximately 50.0% share in the Europe heparin market.

The Europe Heparin Market is segmented into the following categories: 

 

Europe Heparin Market, by Product

  • Unfractionated Heparin
  • Low Molecular Weight Heparin (LMWHs)
  • Ultra-low Molecular Weight Heparin (ULMWHs)

Europe Heparin Market, by Country

  • United Kingdom
    • Unfractionated Heparin
    • Low Molecular Weight Heparin (LMWHs)
    • Ultra-low Molecular Weight Heparin (ULMWHs)
  • Germany
    • Unfractionated Heparin
    • Low Molecular Weight Heparin (LMWHs)
    • Ultra-low Molecular Weight Heparin (ULMWHs)
  • France
    • Unfractionated Heparin
    • Low Molecular Weight Heparin (LMWHs)
    • Ultra-low Molecular Weight Heparin (ULMWHs)
  • Spain
    • Unfractionated Heparin
    • Low Molecular Weight Heparin (LMWHs)
    • Ultra-low Molecular Weight Heparin (ULMWHs)
  • Italy
    • Unfractionated Heparin
    • Low Molecular Weight Heparin (LMWHs)
    • Ultra-low Molecular Weight Heparin (ULMWHs)
  • Rest of the Europe
    • Unfractionated Heparin
    • Low Molecular Weight Heparin (LMWHs)
    • Ultra-low Molecular Weight Heparin (ULMWHs)

 

About Us

 

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. 

 

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

 

Contact

 

Mr.Sudip S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

Back To Top